CATABASIS PHARMACEUTICALS INC (CATB) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 31 transactions totaling $22.2M, demonstrating a bullish sentiment with $22.2M in net insider flow. The most recent transaction on Jun 30, 2015 involved a transaction of 330,098 shares valued at $0.
No significant insider buying has been recorded for CATB in the recent period.
No significant insider selling has been recorded for CATB in the recent period.
Based on recent SEC filings, insider sentiment for CATB is bullish with an Insider Alignment Score of 100/100 and a net flow of $22.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CATABASIS PHARMACEUTICALS INC (CATB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading CATB stock, having executed 31 transactions in the past 90 days. The most active insider is V, Llc Svlsf (Executive), who has made 6 transactions totaling $4.7M.
Get notified when executives and directors at CATB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 30, 2015 | Laufer Ron | Executive | Conversion | 330,098 | $N/A | $0 | |
| Jun 30, 2015 | Laufer Ron | Executive | Conversion | 1,079,115 | $N/A | $0 | |
| Jun 30, 2015 | Laufer Ron | Executive | Purchase | 223,439 | $12.00 | $2.7M | Large |
| Jun 30, 2015 | Inc. Medimmune Ventures, | Executive | Conversion | 330,098 | $N/A | $0 | |
| Jun 30, 2015 | Inc. Medimmune Ventures, | Executive | Purchase | 223,439 | $12.00 | $2.7M | Large |
| Jun 30, 2015 | Inc. Medimmune Ventures, | Executive | Conversion | 1,079,115 | $N/A | $0 | |
| Jun 30, 2015 | C. Milne Jill | Executive | Conversion | 8,189 | $N/A | $0 | |
| Jun 30, 2015 | C. Milne Jill | Executive | Conversion | 66,657 | $N/A | $0 | |
| Jun 30, 2015 | Modi Rick | Executive | Conversion | 4,094 | $N/A | $0 | |
| Jun 30, 2015 | Llc Svlsf V, | Executive | Conversion | 34,893 | $N/A | $0 | |
| Jun 30, 2015 | Llc Svlsf V, | Executive | Conversion | 1,651,223 | $N/A | $0 | |
| Jun 30, 2015 | Llc Svlsf V, | Executive | Purchase | 8,094 | $12.00 | $97.1K | |
| Jun 30, 2015 | Llc Svlsf V, | Executive | Conversion | 764,309 | $N/A | $0 | |
| Jun 30, 2015 | Llc Svlsf V, | Executive | Purchase | 382,996 | $12.00 | $4.6M | Large |
| Jun 30, 2015 | Llc Svlsf V, | Executive | Conversion | 16,152 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 9 | $22.2M | 100.0% |
Conversion(C) | 22 | $0 | 0.0% |
Insiders at CATABASIS PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 10 insiders making 31 transactions totaling $22.2M in purchases versus $0 in sales, the net buying activity of $22.2M signals strong executive confidence. V, Llc Svlsf (Executive) leads the buying activity with $4.7M in transactions across all time.